We are live on ! Find out more
GRCE

Grace Therapeutics
GRCE

33 hedge funds and large institutions have $12.6M invested in Grace Therapeutics in 2019 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

88% more capital invested

Capital invested by funds: $6.67M → $12.6M (+$5.88M)

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

22% more funds holding

Funds holding: 27 → 33 (+6)

0.04% more ownership

Funds ownership: 0.09% → 0.13% (+0.04%)

Holders
33
Holders Change
+6
Holders Change %
+22.22%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
8
Reduced
4
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$1.28M
2
OAM
Oxford Asset Management
United Kingdom
+$568K
3
Renaissance Technologies
Renaissance Technologies
New York
+$452K
4
Morgan Stanley
Morgan Stanley
New York
+$346K
5
Barclays
Barclays
United Kingdom
+$206K

Top Sellers

Rank Fund Capital Flow
1
MFS
Monetta Financial Services
Illinois
-$189K
2
WMSA
Weiss Multi-Strategy Advisers
New York
-$95K
3
BCM
Bayesian Capital Management
New York
-$46K
4
ARTA
A.R.T. Advisors
New York
-$41K
5
PAG
Private Advisor Group
New Jersey
-$30.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$33K +$27.8K +281 New
BDF
27
Balasa Dinverno & Foltz
$31K +$25.7K +260 New
UBS Group
28
UBS Group
Switzerland
$17K +$6.72K +68 +87%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$7K +$1.68K +17 +40%
FDCDDQ
30
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5.03K – – –
ASN
31
Advisory Services Network
Georgia
$5K +$4.15K +42 New
RCA
32
Ranch Capital Advisors
Florida
$3K +$2.47K +25 New
RE
33
RBC Europe
United Kingdom
$74 – – –
MFS
34
Monetta Financial Services
Illinois
– -$189K -2,083 Closed
WMSA
35
Weiss Multi-Strategy Advisers
New York
– -$95K -1,042 Closed
BCM
36
Bayesian Capital Management
New York
– -$46K -502 Closed
ARTA
37
A.R.T. Advisors
New York
– -$41K -450 Closed
HF
38
HRT Financial
New York
– -$25K -276 Closed
SPC
39
Sigma Planning Corp
Michigan
– -$19K -215 Closed
TC
40
Truvestments Capital
Florida
– -$2K -25 Closed
PCM
41
Prelude Capital Management
New York
– -$1K -11 Closed
1
2

GRCE Hedge Fund Activity: Q4 2019 in Review

33 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q4 2019, worth a combined $12.6M — up 88% from $6.67M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new GRCE positions and 9 closed out — a net gain of 6 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $1.28M. The largest seller was Monetta Financial Services, exiting entirely with an estimated $189K sold.

  • 33 institutional investors held Grace Therapeutics (GRCE) as of Q4 2019, up from 27 in Q3 2019.
  • Funds reported $12.6M of Grace Therapeutics stock for Q4 2019, up 88% quarter-over-quarter.
  • 15 funds opened new Grace Therapeutics positions in Q4 2019 and 9 closed out, a net change of +6 holders.
  • The largest Grace Therapeutics buyer in Q4 2019 was Acuta Capital Partners, an estimated $1.28M added.
  • The largest Grace Therapeutics seller in Q4 2019 was Monetta Financial Services, an estimated $189K sold.

Based on aggregated 13F filings for Q4 2019.